You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gucy2c

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumors of Digestive Organs Trial in Hangzhou (gucy2c cart cells)

Recruiting
  • Malignant Neoplasms of Digestive Organs
  • gucy2c cart cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Feb 26, 2022

Malignant Tumors of Digestive Organs Trial in Hefei (gucy2c cart cells)

Not yet recruiting
  • Malignant Neoplasms of Digestive Organs
  • gucy2c cart cells
  • Hefei, Anhui, China
    Anhui provincial cancer hospital
Feb 28, 2021

Colorectal Adenoma, Stage 0 Colorectal Cancer AJCC v8, Stage I Colorectal Cancer AJCC v8 Trial in Philadelphia, Seattle

Recruiting
  • Colorectal Adenoma
  • +10 more
  • Philadelphia, Pennsylvania
  • +2 more
Apr 1, 2022

Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

Active, not recruiting
  • Tauopathies
  • 11C-HY-2-15 PET
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2023

CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in

Not yet recruiting
  • Polymorphism, Genetic
  • +5 more
    • (no location specified)
    Nov 3, 2023

    Coronary Artery Disease, Myocardial Infarction Trial (IVL with Shockwave C2+ 2Hz Coronary IVL Catheter)

    Not yet recruiting
    • Coronary Artery Disease
    • Myocardial Infarction
    • IVL with Shockwave C2+ 2Hz Coronary IVL Catheter
    • (no location specified)
    Jul 28, 2023

    Parkinson Disease Trial (1 : S-C1-C2, 2 : S-C2-C1, 3 : C1 - S - C2)

    Recruiting
    • Parkinson Disease
    • 1 : S-C1-C2
    • +5 more
    • Toulouse, France
      Uh Toulouse
    Nov 3, 2022

    Width and HbA1C in Type 2 Diabetes Mellitus After Glycemic

    Not yet recruiting
    • Type 2 Diabetes
    • Glycated hemoglobin (HbA1C)
    • +2 more
    • (no location specified)
    Sep 28, 2023

    Type 2 Diabetes Trial in Seoul (Treatment Period(JW0201), Treatment Period(Placebo), Extension Period(JW0201))

    Recruiting
    • Type 2 Diabetes Mellitus
    • Treatment Period(JW0201)
    • +2 more
    • Seoul, Korea, Republic of
      Kangbuk Samsung Hospital
    Apr 3, 2023

    Type 2 Diabetes Trial in Gwangju (JW0201, Placebo)

    Recruiting
    • Type 2 Diabetes Mellitus
    • Gwangju, Korea, Republic of
      Chosun University Hospital
    Apr 3, 2023

    Clinical Performance Evaluation of the C2i Test

    Not yet recruiting
    • Muscle Invasive Bladder Cancer
    • C2i-WGS-MRD Test
    • (no location specified)
    May 5, 2023

    Diabetes, Type 2 Trial in Beijing (HbA1c prediction)

    Recruiting
    • Diabetes Mellitus, Type 2
    • HbA1c prediction
    • Beijing, Chongqing, China
      Peking University People's Hospital
    Apr 9, 2023

    Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • C3 (Metformin, Simvastatin, and Digoxin)
    • (no location specified)
    Sep 1, 2023

    Type2diabetes, Endothelial Dysfunction Trial in Malmö (C21)

    Recruiting
    • Type2diabetes
    • Endothelial Dysfunction
    • Malmö, Sweden
      Skånes universitetssjukhus
    Apr 25, 2023

    Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

    Recruiting
    • Chronic Hepatitis C Virus
    • +4 more
    • Bucuresti, BUC, Romania
      Atea Study Site
    Jun 15, 2023

    Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

    Not yet recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Aug 23, 2023

    HER2-positive Advanced Solid Tumors Trial in Shanghai (DP303c)

    Recruiting
    • HER2-positive Advanced Solid Tumors
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Apr 10, 2023

    Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

    Active, not recruiting
    • Malignant Solid Neoplasm
    • Biopsy
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Nov 15, 2023

    Melasma Trial (Fractional co2 laser)

    Not yet recruiting
    • Melasma
    • Fractional co2 laser
    • (no location specified)
    Jun 11, 2023

    Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)

    Not yet recruiting
    • Atrial Fibrillation
    • Coronary Artery Disease
    • (no location specified)
    Oct 22, 2023

    Prostate Cancer Trial (BP-C2)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jan 10, 2023

    Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

    Enrolling by invitation
    • Breast Cancer Female
    • Tomsk, Russian Federation
      Olga
    Jun 19, 2023

    ALS Trial ([11C]CPPC PET ligand)

    Not yet recruiting
    • ALS
    • [11C]CPPC PET ligand
    • (no location specified)
    Jan 9, 2023

    Social Inclusion, Mental Illness, Substance Use Disorders Trial in London (Peer to Community (P2C) Model, Care as Usual (UC))

    Active, not recruiting
    • Social Inclusion
    • +2 more
    • Peer to Community (P2C) Model
    • Care as Usual (UC)
    • London, Ontario, Canada
      Western University
    May 31, 2023

    Atopic Dermatitis Trial in Montréal (Triamcinolone Acetonide (Aristocort® C), Vehicle)

    Recruiting
    • Atopic Dermatitis
    • Triamcinolone Acetonide (Aristocort® C)
    • Vehicle
    • Montréal, Quebec, Canada
      Innovaderm Research Inc.
    Apr 25, 2023